baber/WOPTO huggingface dataset:
Patent NZ-591188-A (NZ)
Title: West nile virus vaccine
Inventor: HENNESSY KRISTINA J
IPC: A61K39/12
Filed: 2009-08-31
Abstract: Provided is an immunogenic composition comprising one or more strains of killed or inactivated West Nile Virus or any antigen thereof, wherein said immunogenic composition further comprises at least one antigen of one or more additional strains selected from the group consisting of Eastern Equine Encephalomyelitis Virus, Western Equine Encephalomyelitis Virus and Venezuelan Equine Encephalomyelitis Virus, Tetanus Toxoid, and combinations thereof. The compositions are especially useful as horse vaccines.
Patent NZ-591993-A (NZ)
Title: Flow generator message system correlated to event or trigger detected by sensor
Inventor: OATES JOHN DAVID
IPC: A61M16/00
Filed: 2006-10-13
Abstract: 591993 A flow generator for use with a continuous positive airway pressure (CPAP) system or a non-invasive positive pressure ventilation (NIPPV) system configured to supply breathable gas to a patient at a pressure elevated above atmospheric pressure. The flow generator comprises: a motor configured to generate the supply of breathable gas to a patient; at least one operation sensor (34) to generate signals; and a processor (18) to control flow generator operations. The processor is configured to: correlate the signals of the at least one operation sensor to a particular event or initiate a first response when the particular event or trigger is first correlated with the signals; and initiate a second response that is changed from the first response based on the further detection of the correlated particular event or trigger.
Patent NZ-592440-A (NZ)
Title: A multi-layer cathode block having differential expansion indexes for an electrolytic cell
Inventor: CAMIRE JEAN
IPC: B05D5/12
Filed: 2009-04-30
Abstract: A multi-layer cathode block for an electrolytic cell having at least a surface layer having a surface expansion index and a second layer having a second expansion index is disclosed, wherein the surface layer including a surface wetting agent in a first total amount; and the second layer including a wetting agent in a second total amount, wherein the surface wetting agent and the wetting agent are selected from the group comprising: a metal boride, metal boride precursors, and mixtures of the metal boride and metal boride precursors; the surface layer being directly superposed to the second layer, the wetting agent in the second layer including metal boride precursors that react together to generate a metal boride component in situ when the cathode block is exposed to start-up and operation conditions of the electrolytic cell, the second total amount being lower than the first total amount, and selected so as to minimize the difference between the expansion indexes of the surface layer and the second layer. Also disclosed is a process of producing multi-layer cathode structures having at least a surface layer with a surface expansion index and a second layer with a second expansion index, the process includes the steps of: (a) forming the second layer containing a carbonaceous material and a wetting agent in a second total amount, the wetting agent including metal boride precursors that react together to generate a metal boride component in situ when the cathode block is exposed to start-up and operation conditions of an electrolytic cell; and (b) superposing the surface layer to the second layer, the surface layer including a surface wetting agent in a first total amount, wherein the total amount of wetting agent in the second layer and the surface layer decreases progressively as the distance between the layer and the surface increases and the difference between the expansion indexes is selected to minimize surface cracking.
Patent NZ-593279-A (NZ)
Title: Aroylamino - and heteroaroylamino-substituted piperidines as glyt-1 inhibitors
Inventor: KOLCZEWSKI SABINE
IPC: C07D211/56
Filed: 2010-01-19
Abstract: Disclosed herein are heteroaroylamino substituted piperidine compounds of general formula I, wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are used as inhibitors of glycine transporter 1 (GlyT-1) and also have good selectivity to glycine transporter 2 (GlyT-2) inhibitors, as such are useful in the treatment of pyschoses, pain, dysfunction in memory and learning, attention deficit, schizophrenia, dementia disorders or Alzheimer's disease.
Patent NZ-594125-A (NZ)
Title: Detection devices and methods
Inventor: DAVIS RANDY ALEKS
IPC: G01N31/22
Filed: 2010-01-14
Abstract: 594125 Disclosed herein are devices and methods for rapid and easy to use quantitative detection of one or more analytes in, for example, food, food ingredients, drinking water or pharmaceuticals. Analytes that can be detected by the devices and methods herein include, for example, adulterants, toxins, allergens, pathogens, pesticides, pharmaceuticals, pharmaceutical intermediates, biopolymers and biotechnology products.
Patent NZ-598076-A (NZ)
Title: Fibrous product with a top ply having embossing protuberances and further middle and bottom plies
Inventor: HARLACHER HARALD
IPC: B31F1/07
Filed: 2009-09-22
Abstract: 598076 A fibrous product, especially tissue paper product, non-woven product or a hybrid thereof and preferably hygiene and cleaning product. The product comprises at least: one top ply (12) with either an embossing pattern forming pillow-like chambers (20) at least partially surrounded by first embossing protuberances (18) or with second embossing protuberances; at least one middle ply (14) embossed in register with the at least one top ply (12) so that either second embossing protuberances (22) of the at least one middle ply (14) nest into the pillow-like chambers (20) of the at least one top ply (12) or second embossing protuberances of the at least one top ply (12) nest into the pillow-like chambers at least partially surrounded by first embossing protuberances of the at least one middle ply; and at least one bottom ply (16) not in register with the at least one top ply (12) and being bonded to both the at least one top ply (12) and the at least one middle ply (14).
Patent NZ-598215-A (NZ)
Title: Fuel cell
Inventor: HUMAN JAN PETRUS
IPC: C25B9/19
Filed: 2010-08-16
Abstract: A fuel cell comprises a casing (12) and an electrode assembly in the casing. The electrode assembly comprises a porous substrate (36), a first electrode (46) on one side of the substrate and a second electrode (48) on the same side of the substrate. Third and fourth electrodes (60, 62) are provided on the other side of the substrate. Each electrode includes a tab (36, 38, 42, and 44) by means of which an electrical connection can be made to that electrode. There is electrolyte in the casing.
Patent NZ-603500-A (NZ)
Title: Process for the production of substitute natural gas
Inventor: EASTLAND PHILIP HENRY DONALD
IPC: C10L3/08
Filed: 2011-06-27
Abstract: 603500 Disclosed is a process for the production of substitute natural gas comprising: providing a feed gas to a first and/or second and/or subsequent bulk methanator; subjecting that feed gas to methanation in the presence of a suitable catalyst; removing an at least partially reacted stream from the first bulk methanator and supplying it to the second and/or subsequent bulk methanator where it is subjected to further methanation; passing a product stream from the final bulk methanator to a trim methanator train where it is subjected to further methanation; removing a recycle stream downstream of the first, second or subsequent bulk methanator, and, in any order, passing it through a compressor, subjecting it to cooling and then supplying to a trim and/or recycle methanator for further methanation before being recycled to the first and/or second and/or subsequent methanator.
Patent NZ-606177-A (NZ)
Title: Compositions for the treatment of actinic keratosis
Inventor: DR JUERGEN WARNECKE
IPC: A61P17/02
Filed: 2013-01-25
Abstract: 606177 The disclosure relates to the use of ibuprofen in the manufacture of a medicament for prevention and treatment of actinic keratosis and pharmaceutical compositions for such purposes. The medicament disclosed maybe from 1 to 20% by weight ibuprofen and may contain the following as penetration enhancer’s dimethyl isosorbide, poloxamers, laurocapram, pyrrolidones, dimethylsulfoxide, oleic acid and ethylene glycols. The composition may further contain diclofenac and in one preferred embodiment contains no Hyaluronic acid.
Patent NZ-612912-A (NZ)
Title: Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{ 1-hydroxy-1-methyl-ethyl} pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl} -1h-benzimidazol-2-yl]urea
Inventor: SHANNON DEAN
IPC: C07D407/04
Filed: 2012-01-13
Abstract: The disclosure relates to solid forms of compound of formula (I) and pharmaceutically acceptable salts thereof, particularly the hydrochloride salt and the solid amorphous mesylate salt, that inhibit bacterial enzymes gyrase and/or topoisomerase IV. Also disclosed are pharmaceutical compositions comprising said compound of formula (I) or its salts and their use for treating bacterial infection.
Patent NZ-616977-A (NZ)
Title: Culture medium for human mesenchymal stem cells
Inventor: GAJARDO RODRIGUEZ RODRIGO
IPC: C12N5/0775
Filed: 2013-10-23
Abstract: Disclosed is a culture medium for human mesenchymal cells, comprising: a) basal medium suitable for the culture of mesenchymal stem cells; b) human leucocyte/platelet coat lysate (buffy coat); c) insulin; d) sodium selenite; e) ethanolamine; f) basic fibroblast growth factor (bFGF); and either g) fetal bovine serum; or h) cell culture supplement from human plasma (CCS); or both g) and h).
Patent NZ-617022-A (NZ)
Title: Improvements in and relating to the manufacture of granular material
Inventor: ROBERT HAMILTON HALL
IPC: C05G3/00
Filed: 2012-10-25
Abstract: A grinding apparatus for finely grinding material and for granulating that material is disclosed. The apparatus includes a chamber (2), grinding means (3c) and pelletising means (4). The grinding means (3c) and pelletising means (4) are housed within the chamber (2). The grinding means (3c) are adapted to both grind the material to effect finely ground material particles and apply pressure to subsequently compress the finely ground material particles into granules via the pelletising means (4). One or both of the grinding means (3c) and the pelletising means (4) are configured to maximise the residence time of the material in contact with the grinding means (3c) to effect the finely ground material component to produce granules formed via the pelletising means in a single-pass, one operation grinding and pelleting process. The granules formed include a fine to superfine particle portion of fine particles in the range of less than 75 micron and less than 45 micron in size, respectively. Granules of material and a method of manufacturing granules of material are also disclosed.
Patent NZ-619979-A (NZ)
Title: Papaver somniferum with high concentration of codeine
Inventor: FIST ANTHONY J
IPC: A01H1/06
Filed: 2009-05-28
Abstract: Disclosed is a plant of Papaver somniferum produced by the process of: a) exposing at least one poppy seed of Papaver somniferum to a mutagenizing agent, b) growing at least one mutagenized poppy seed to produce a plant bearing a leaf or an immature poppy capsule, optionally through multiple self- fertilized generations, c) sampling the leaf or poppy capsule of the plant(s) grown in b) for the presence of thebaine, oripavine, morphine and codeine, d) repeating steps a) to c) until a poppy plant of Papaver somniferum is obtained having codeine constituting about 40% by weight or greater, and having thebaine constituting about 40% by weight or less, of the alkaloid combination, wherein the alkaloid combination comprises morphine, codeine, thebaine and oripavine; and e) collecting the seed from the plant obtained in “d” and growing another generation of plants to ensure that the subsequent generation stably re-produces the high codeine and low morphine characteristic, wherein the plant yields a poppy straw having codeine constituting about 40% by weight or greater of an alkaloid combination; or yields a poppy straw having a codeine content of about 0.8% to about 4.2% in the poppy straw on a dry weight basis; or yields a poppy straw containing greater than 0.8% codeine on a dry weight basis and wherein the ratio of codeine and thebaine to an alkaloid combination comprising morphine, codeine, thebaine and oripavine is between about 0.90 and about 1.00; or yields a poppy straw wherein the ratio of codeine to an alkaloid combination comprising morphine, codeine, thebaine and oripavine is about 0.40 or greater.
Patent NZ-624057-A (NZ)
Title: Method of treating or reducing efp
Inventor: HART SUSAN G EMEIGH
IPC: A61K38/48
Filed: 2012-10-19
Abstract: Disclosed is the use of collagenase for the preparation of a medicament for treating or reducing edematous fibrosclerotic panniculopathy (EFP) in a patient, wherein said medicament is formulated for administration of at least one subdermal in injection of recombinant collagenase or collagenase purified from Clostridium histolyticum comprising collagenase I and collagenase II to an area affected by EFP, wherein the dose of collagenase per injection is between about 5 to about 200 ABC units.
Patent NZ-707495-A (NZ)
Title: Tricyclic fused thiophene derivatives as jak inhibitors
Inventor: ZHU WENYU
IPC: A61K31/437
Filed: 2013-10-31
Abstract: The present invention provides tricyclic fused thiophene derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase (JAK) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
Patent NZ-742545-A (NZ)
Title: Methods and compositions for treatment of a genetic condition
Inventor: REBAR EDWARD J
IPC: C12N15/62
Filed: 2013-08-29
Abstract: The present disclosure is directed towards methods and composition for a genetic disease. More specifically, the present disclosure is in the field of genome engineering of hematopoietic stem cells. There is a need for additional methods and compositions that can be used for genome editing, to correct an aberrant gene or alter the expression of others for example to treat hemoglobinopathies.
Patent NZ-747298-A (NZ)
Title: Methods and compositions for treatment and control of plant disease
Inventor: YOUNG RYLAND F
IPC: C12N1/06
Filed: 2013-10-18
Abstract: The present invention provides methods for development of a virulent bacteriophage-based treatment for the control of plant diseases caused by Xylella fastidiosa. The invention further provides methods of isolating and propagating bacteriophage virulent to X. fastidiosa in a Xanthomonas bacterial host and for treating or reducing symptoms of X. fastidiosa infection in a plant. The invention further provides methods of isolating and propagating bacteriophage virulent to Xanthomonas axonopodis pv. citri and for treating or reducing symptoms of Xanthomonas axonopodis pv. citri infection in a plant. In particular, the present invention relates to a plant disease biocontrol composition comprising a combination/phage cocktail of both Xfas100 type phages which have a morphology typical of Siphoviridae and Xfas300 phage types which have a morphology typical of Podoviridae. Both phage types are virulent to Xylella fastidiosa and Xanthomonas species.
Patent NZ-757175-A (NZ)
Title: Electronic vapour provision system
Inventor: FRASER RORY
IPC: A24F40/30
Filed: 2016-06-15
Abstract: An electronic vapour provision system comprises a control unit and a cartridge configured to engage with and disengage from one another substantially along said longitudinal axis. The cartridge includes a reservoir of liquid to be vaporised, and the control unit includes a battery and a tube portion disposed along said longitudinal axis. The tube portion comprises an inner wall and an outer wall. The system further comprises an induction heating assembly comprising a drive coil and a heater element. The heater element is located in the cartridge for vaporising the liquid. The cartridge is configured to feed liquid from the reservoir onto the heater element for vaporisation. The drive coil is located in the tube portion of the control unit, between the inner wall and the outer wall of the tube portion, and disposed about said longitudinal axis. The cartridge is located at least partly within the inner wall of the tube portion when engaged with the control unit, such that the heater element is within the drive coil. The heater element is configured such that a space is provided to allow for air to flow through the air passageway and around the heater element.
Patent NZ-767146-A (NZ)
Title: A seating support
Inventor: MASCULL BRUCE GORDON
IPC: A61G5/10
Filed: 2019-02-26
Abstract: The invention provides a customisable seating support for a seat base that is particularly useful for supporting a physically disabled person in a chair, such as a wheelchair. People with physical disabilities often have different support requirements for seats and these requirements may change over time. It is therefore helpful if seating can be customised to meet the requirements of individual chair users, especially people who may also require specialized seating to assist with their positioning in a wheelchair or other form of chair or seat. The seating support includes a posterior portion and a pair of first and second thigh supports that are connected to the posterior portion, via a multi-directional connection, so that the position of at least one thigh support is independently adjustable to tilt upwardly or downwardly or to pivot outwardly relative to the posterior portion to an abducted position. The first thigh support is also externally rotatable outwardly and away from the second thigh support to form an abducted position and the second thigh support is internally rotatable toward the first thigh support in an adducted position, so that both the first and second thigh supports are rotated toward one side of the seating support. These features allow for the seat to be cutomisable to the user’s needs.
Patent NZ-769599-A (NZ)
Title: Animal tag
Inventor: SMITH DAVID IAN
IPC: A01K11/00
Filed: 2019-05-15
Abstract: Existing animal ear tags fail to accommodate electronics such that they can be easily engaged and disengaged from the animals ear. The present invention addresses this by providing an animal tag for attachment to an ear of an animal, the tag comprising: a first tag member adapted to be mounted to any one of an outer surface or an inner surface of the animal’s ear; a second tag member adapted to be mounted to the other of the outer or inner surface of the animal’s ear; a connecting arrangement for inter- connecting the first and second tag member, the connecting arrangement comprising an attachment member having a head portion adapted to be retained in the first tag member and a shank portion adapted to be retained in the second tag member.
Patent PT-105343-A (PT)
Title: Produto limpador de vasos sanitários contido dentro de um dispositivo de deslocamento de água
Inventor: SILVA MARIA FILOMENA FIGUEIRA DA
IPC: E03D9/02
Filed: 2010-10-18
Abstract: A INVENÇÃO É CARACTERIZADA POR UM PRODUTO LIMPADOR DE VASOS SANITÁRIOS, UM MATERIAL ABSORVENTE CONTIDO DENTRO DE UM RECIPIENTE FLEXÍVEL (1) E UM GANCHO SUJEITADOR (2). QUANDO O RECIPIENTE FLEXÍVEL SE ENCONTRA SUBMERGIDO NA ÁGUA DO TANQUE DO SANITÁRIO, O MATERIAL ABSORVENTE COMEÇA A ABSORVER A ÁGUA QUE PASSA PELAS PERFURAÇÕES DO RECIPIENTE FLEXÍVEL E, AO MESMO TEMPO, O PRODUTO LIMPADOR DE SANITÁRIOS, QUE TEM UMA CONCENTRAÇÃO IÓNICA CONTROLADA, DILUI-SE E FORMA-SE UMA SOLUÇÃO DE LIMPEZA QUE NÃO AFECTA A CAPACIDADE DE ABSORÇÃO DO MATERIAL ABSORVENTE, FICANDO CONTIDA DENTRO DO RECIPIENTE FLEXÍVEL, E CADA VEZ QUE O TANQUE DO SANITÁRIO É ESVAZIADO LIBERTA-SE UMA PEQUENA QUANTIDADE DA SOLUÇÃO DE LIMPEZA E TAMBÉM SE POUPA UM VOLUME DE ÁGUA DEVIDO AO VOLUME DA ÁGUA DESLOCADO PELO RECIPIENTE FLEXÍVEL.
Patent PT-105484-A (PT)
Title: Um método de ambientómica funcional para engenharia de meio de cultura celular
Inventor: OLIVEIRA RUI MANUEL FREITAS
IPC: C12N5/02
Filed: 2011-01-14
Abstract: ESTA INVENÇÃO REFERE-SE A UM NOVO MÉTODO PARA A OPTIMIZAÇÃO DA COMPOSIÇÃO DE UM MEIO PARA A CULTURA DE CÉLULAS. ESTE NOVO MÉTODO COMPREENDE DUAS FASES PRINCIPAIS. NA PRIMEIRA FASE, CONSTRÓI-SE UM MAPA DE AMBIENTÓMICA FUNCIONAL ATRAVÉS DO RASTREIO CONJUNTO DE FUNÇÕES CELULARES E DE FACTORES DO MEIO ATRAVÉS DA REALIZAÇÃO DE UM PROTOCOLO DE CULTURA CELULAR ESPECÍFICO E DE UM PROTOCOLO DE TESTES DE EXOMETABOLOMA. O MAPA DE AMBIENTÓMICA FUNCIONAL CONSISTE NUMA MATRIZ DE DADOS DE VALORES DE INTENSIDADE DE FUNÇÕES CELULARES ELEMENTARES EM RELAÇÃO A FACTORES DO MEIO. NA SEGUNDA FASE, SÃO DESENVOLVIDAS FORMULAÇÕES OPTIMIZADAS DO MEIO DE CULTURA CELULAR PARA OU AUMENTAR OU INIBIR FUNÇÕES CELULARES ELEMENTARES ALVO A PARTIR DE COLUNAS DO MAPA DE AMBIENTÓMICA FUNCIONAL. A PRINCIPAL VANTAGEM DESTE MÉTODO É A DE PERMITIR ENGENHARIA METABÓLICA ATRAVÉS DA MANIPULAÇÃO DA COMPOSIÇÃO DO MEIO DE CULTURA, EM QUE SE OPTIMIZA UM NÚMERO ARBITRARIAMENTE ELEVADO DE FUNÇÕES CELULARES ATRAVÉS DA MANIPULAÇÃO DE FACTORES DO MEIO, EM CONTRASTE COM MÉTODOS ANTERIORES, OS QUAIS SÃO EMINENTEMENTE EMPÍRICOS, NÃO SÃO ORIENTADOS PARA AS FUNÇÕES CELULARES, E NECESSITAM DE UM NÚMERO DE EXPERIÊNCIAS MUITO SUPERIOR. ALÉM DISSO, ESTE NOVO MÉTODO BASEIA-SE EM TESTES DE EXOMETABOLOMA E NÃO NECESSITA DE TESTES GENÓMICOS OU PROTEÓMICOS INTRACELULARES ONEROSOS.
Patent RU-94002912-A (RU)
Inventor: STEKOL NIKOV L I
IPC: A61K38/43
Filed: 1994-01-28
Abstract: FIELD: enzymology. SUBSTANCE: streptolyase is a preparation containing enzyme streptokinase isolated from hemolytic streptococcus C culture. Method involves streptolyase dissolving, addition of polymeric saccharide to solution, stirring and sterilizing filtration. Solvent: 2-6% glucose aqueous solutions. Polymeric polysaccharide: hyaluronic acid taken at amount 1-2 mg per 100000 U streptolyase. Also, ascorbic acid is added to solution at amount 20-30 mg per 100 ml. Streptolyase preparation is used in medicine. EFFECT: enhanced stability at storage.
Patent RU-94009793-A (RU)
Inventor: DANILOV V T
IPC: B23K11/30
Filed: 1994-03-22
Abstract: FIELD: welding production, namely, electrodes for contact spot welding. SUBSTANCE: electrode assembly has cooling system with tube for supplying cooling liquid and connected with water supply line and arranged inside central cooling duct. Electrode holder has through opening for liquid removal. Valve mounted on inner side of electrode has through radial openings in its upper portion. The valve body is also provided with through radial openings in its upper and lower portions. EFFECT: enhanced quality of welding due to effective cooling of working electrode end and increased service life of electrode.